Literature DB >> 23204473

Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisal.

Neil E Anderson1, Kong Chung, Ernie Willoughby, Michael S Croxson.   

Abstract

OBJECTIVE: To determine the frequency and range of neurological manifestations of phaeochromocytomas and secretory paragangliomas.
METHODS: A retrospective review of case notes of patients admitted to Auckland Hospital from 1985 to 2011 with a discharge diagnosis of phaeochromocytoma or secretory paraganglioma.
RESULTS: Ninety-three patients were admitted with a phaeochromocytoma or secretory paraganglioma. Sixty-eight patients (73%) had neurological symptoms, but only 15 patients (16%) received a neurological consultation. Neurological manifestations occurred in three main clinical contexts. First, paroxysmal symptoms occurred in 66 of 93 patients (71%). Neurological symptoms were common features of these attacks and included headache (47 patients), anxiety (24 patients), tremulousness (15 patients) and dizziness (12 patients). The headaches typically had an explosive onset. Delay in diagnosis was common. Second, 28 patients (30%) had an acute crisis, which was associated with neurological symptoms in 11 (39%) of the episodes: headache (10 patients); seizures (five patients); strokes (three patients); delirium (three patients) and subarachnoid haemorrhage (one patient). Third, five of six patients with a head and neck secretory paraganglioma had neurological symptoms related to infiltration of the middle ear or compression of cranial nerves. Reversible cerebral vasoconstriction syndrome (RCVS) was documented in three patients.
CONCLUSIONS: Neurological manifestations of phaeochromocytomas and secretory paragangliomas were common, and these tumours can present with various neurological manifestations. The paroxysmal symptoms can be incorrectly attributed to other headache syndromes, panic attacks or cerebral vasculitis. RCVS may play a role in the pathogenesis of the neurological symptoms associated with acute crises and paroxysmal attacks.

Entities:  

Mesh:

Year:  2012        PMID: 23204473     DOI: 10.1136/jnnp-2012-303028

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Drug-resistant epilepsy, early-onset hypertension and white matter lesions: a hidden paraganglioma.

Authors:  Katri Silvennoinen; Alison J Waghorn; Simona Balestrini; Sanjay M Sisodiya
Journal:  BMJ Case Rep       Date:  2019-06-21

2.  Catecholamine-induced cerebral vasospasm and multifocal infarctions in pheochromocytoma.

Authors:  Jai Madhok; Amy Kloosterboer; Chitra Venkatasubramanian; Frederick G Mihm
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2020-08-20

Review 3.  Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome.

Authors:  Tariq A Hammad; Rula A Hajj-Ali
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.967

4.  Atypical presentation of pheochromocytoma: Central nervous system pseudovasculitis.

Authors:  Ketankumar Rupala; Varun Mittal; Rajiv Gupta; Rajiv Yadav
Journal:  Indian J Urol       Date:  2017 Jan-Mar

5.  Reversible Cerebral Vasoconstriction Syndrome in the Setting of COVID-19 and Pleomorphic Sarcoma: A Case Report.

Authors:  Ehab Harahsheh; David Gritsch; Amir Mbonde; Michael Apolinario; Joseph M Hoxworth; Bart M Demaerschalk
Journal:  Neurologist       Date:  2022-05-01       Impact factor: 1.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.